Physician profile
William E Aukerman
NPI 1932629250
$5,586.69
in general payments reported to CMS, 2019-2025
26 companies · $1,808 in 2025
The $1,808 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $39.45 · 2021: $487 · 2022: $240 · 2023: $460 · 2024: $2,267 · 2025: $1,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,312 · Travel and Lodging: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,312.28 |
| Travel and Lodging | $1,222.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,128.22 | 2024-2025 | |
| Synthes Gmbh | $457.80 | 2024 | |
| Integra Lifesciences Corporation | $450.88 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $442.01 | 2021-2022 | |
| Avita Medical Americas, LLC | $413.90 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Ethicon US, LLC | $340.55 | 2019-2023 | Stratafix |
| Organogenesis INC. | $299.42 | 2024-2025 | Puraply Wound Matrix |
| Mentor Worldwide LLC | $256.05 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $245.80 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Baxter Healthcare | $200.32 | 2024-2025 | |
| Innovation Technologies INC | $178.93 | 2025 | Irrisept |
| Becton, Dickinson and Company | $153.10 | 2025 | Phasix Mesh |
| Biotissue Holdings INC. | $149.22 | 2024 | |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Kerecis Limited | $134.89 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $132.20 | 2025 | |
| Depuy Synthes Sales INC. | $126.46 | 2021-2025 | Na, Va-Lcp |
| Polynovo North America LLC | $113.45 | 2024 | Novosorb Btm |
| Bard Peripheral Vascular, INC. | $48.01 | 2021 | |
| Kci USA, INC. | $44.02 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Lemaitre Vascular, INC. | $34.82 | 2022-2023 | Artegraft Vascular Graft |
| Csl Behring | $29.68 | 2021 | |
| Acera Surgical, INC. | $27.26 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $15.60 | 2021 | |
| Hydrofera LLC | $12.93 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Aukerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.